Matthew Page is a Senior Research Fellow, Future Leader Postdoctoral Fellow and Deputy Head of the Methods in Evidence Synthesis Unit in the School of Public Health and Preventive Medicine at Monash University. He leads a program of research on methods for evidence synthesis, which builds on the research undertaken during his PhD (2011-2015), NHMRC Early Career Fellowship (2015-2019) and ARC Discovery Early Career Researcher Award (2020-2023). He was a visiting postdoctoral fellow at the University of Bristol, UK, from 2015-2017.

Matthew's research aims to improve the credibility of syntheses of health and medical research. He has led many studies investigating the transparency, reproducibility and risk of bias in systematic reviews and the studies they include, and has developed methods to address these issues. He co-led the development of the PRISMA 2020 statement, a highly cited reporting guideline for systematic reviews, and was a member of the core group who developed the RoB 2 tool for assessing risk of bias in randomized trials. He was an associate scientific editor for the 2019 edition of the Cochrane Handbook for Systematic Reviews of Interventions. He has collaborated on many systematic reviews and meta-analyses evaluating the effects of various interventions for a range of health conditions, including manual therapy and exercise for shoulder pain, splinting for carpal tunnel syndrome, drug and non-drug therapies for attention deficit hyperactivity disorder, and testosterone replacement therapy for sexual wellbeing; this applied work often informs his research agenda. 

Matthew's expertise has been recognized in leadership and editorial appointments at organizations and journals focusing on methods for evidence synthesis, including co-convenor of the Cochrane Bias Methods Group, and member of the editorial board for the Journal of Clinical Epidemiology. In 2022 he served as President of the Association for Interdisciplinary Meta-research and Open Science (AIMOS).